PharmacologyCVSAntiarrhythmic drugs: Flecainide (Class 1C)

Antiarrhythmic drugs: Flecainide (Class 1C)

-

Introduction

Flecainide is an antiarrhythmic agent classified under subgroup 1C. It is a potent blocker of sodium and potassium channels with slow unblocking kinetics. While it is effective in treating certain types of arrhythmias, its use is associated with significant risks, including a potential increase in mortality. This article will explore the mechanism of action, risks, and therapeutic uses of flecainide.

Mechanism of Action

Flecainide

  • Sodium and Potassium Channel Blockade: Flecainide effectively blocks both sodium and potassium channels, albeit with slow unblocking kinetics.
  • No QT Interval Prolongation: Unlike some other antiarrhythmic agents, flecainide does not prolong the action potential or the QT interval.
  • No Antimuscarinic Effects: Flecainide does not have antimuscarinic properties.

Therapeutic Uses

  • Supraventricular Arrhythmias: Flecainide is used for patients with otherwise normal hearts who suffer from supraventricular arrhythmias.
  • Premature Ventricular Contractions: The drug is very effective in suppressing premature ventricular contractions.

Risks and Limitations

  • Exacerbation of Arrhythmia: Flecainide can severely exacerbate arrhythmias, even at normal doses, in patients with preexisting ventricular tachyarrhythmias and those with a history of myocardial infarction and ventricular ectopy.
  • Increased Mortality: The Cardiac Arrhythmia Suppression Trial (CAST) was terminated prematurely due to a two and one-half-fold increase in mortality rate among patients receiving flecainide and similar group 1C drugs.

Pharmacokinetics

  • Absorption and Half-Life: Flecainide is well absorbed and has a half-life of approximately 20 hours.
  • Elimination: The drug is eliminated both by hepatic metabolism and by the kidneys.
  • Dosage: The usual dosage of flecainide is 100–200 mg twice a day.

Conclusion

Flecainide is a potent antiarrhythmic agent with specific indications, particularly for treating supraventricular arrhythmias in patients with otherwise normal hearts. However, its use comes with significant risks, including the potential for exacerbating existing arrhythmias and increasing mortality. Therefore, flecainide should be used cautiously and under close medical supervision, taking into account its pharmacokinetics and the specific needs of the patient.

Note: This article is intended for educational purposes and should not be considered as medical advice. Always consult with a healthcare professional for medical advice and treatment.

Oh hi there 👋

Sign up to receive awesome content in your inbox, every month.

We don’t spam! Read our privacy policy for more info.

Oh hi there 👋

Sign up to receive awesome content in your inbox every month.

We don’t spam! Read our privacy policy for more info.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always seek the advice of a healthcare provider with any questions regarding a medical condition.

1 COMMENT

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Latest articles

Inflammatory Bowel Disease (IBD)

Introduction Inflammatory Bowel Disease (IBD) is a term that encompasses two main chronic conditions: Crohn's disease and ulcerative colitis. These...

Irritable Bowel Syndrome (IBS)

Introduction Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder characterized by a group of symptoms that typically occur together....

Gastroesophageal Reflux Disease (GERD)

Introduction Gastroesophageal Reflux Disease (GERD) is a chronic digestive disorder marked by the recurrent reflux of stomach contents, particularly gastric...

Peptic Ulcer Disease (PUD)

Introduction Peptic Ulcer Disease (PUD) is a gastrointestinal disorder characterized by sores or lesions in the lining of the stomach...

Helicobacter pylori Infection and Treatment

Introduction Helicobacter pylori (H. pylori) is a bacterium that infects the stomach lining and is a common cause of peptic...

Zollinger-Ellison Syndrome (ZES)

Zollinger-Ellison Syndrome (ZES) is a rare digestive disorder characterized by the development of one or more tumors, known as...

Helicobacter pylori Infection and Treatment

Introduction Helicobacter pylori (H. pylori) is a bacterium that infects the stomach lining and is a common cause of peptic...

Zollinger-Ellison Syndrome (ZES)

Zollinger-Ellison Syndrome (ZES) is a rare digestive disorder characterized by the development of one or more tumors, known as...

Miscellaneous

Pharmacology of Levocetirizine

Introduction Levocetirizine is a second-generation antihistamine that is used to treat symptoms associated with chronic allergic rhinitis and uncomplicated cases...

Pharmacology of Histamine and Antihistamines

Histamine, a pivotal mediator in various physiological and pathological processes, is synthesized from the amino acid L-histidine. This transformation...

You might also likeRELATED
Recommended to you

Pharmacology Mentor We would like to show you notifications for the latest news and updates.
Dismiss
Allow Notifications